In Situ Immunomodulation With CDX-301, Radiation Therapy, CDX-1140 and Poly-ICLC in Patients w/ Unresectable and Metastatic Solid Tumors
University of Southern California
University of Southern California
Thomas Jefferson University
Thomas Jefferson University
Centre Hospitalier Universitaire Vaudois
Ohio State University Comprehensive Cancer Center
Stanford University
Adaptimmune
Pfizer
Duke University